| Title : Treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin improves fasting islet-cell function in subjects with type 2 diabetes - D'Alessio_2009_J.Clin.Endocrinol.Metab_94_81 |
| Author(s) : D'Alessio DA , Denney AM , Hermiller LM , Prigeon RL , Martin JM , Tharp WG , Saylan ML , He Y , Dunning BE , Foley JE , Pratley RE |
| Ref : J Clinical Endocrinology Metab , 94 :81 , 2009 |
| Abstract : D'Alessio_2009_J.Clin.Endocrinol.Metab_94_81 |
| ESTHER : D'Alessio_2009_J.Clin.Endocrinol.Metab_94_81 |
| PubMedSearch : D'Alessio_2009_J.Clin.Endocrinol.Metab_94_81 |
| PubMedID: 18957505 |
D'Alessio DA, Denney AM, Hermiller LM, Prigeon RL, Martin JM, Tharp WG, Saylan ML, He Y, Dunning BE, Foley JE, Pratley RE (2009)
Treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin improves fasting islet-cell function in subjects with type 2 diabetes
J Clinical Endocrinology Metab
94 :81
D'Alessio DA, Denney AM, Hermiller LM, Prigeon RL, Martin JM, Tharp WG, Saylan ML, He Y, Dunning BE, Foley JE, Pratley RE (2009)
J Clinical Endocrinology Metab
94 :81